Thomas G. Moens
Garscube Estate
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Functional Exploration of African Colorectal Cancer Patients Using Personalised Drosophila Avatars.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Human FUS is toxic via association with RNA polymerase II in Drosophila.
Journal: Cell death & disease
Published: May 23, 2025
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications.
Journal: The Lancet. Neurology
Published: July 10, 2024
C21ORF2 mutations point towards primary cilia dysfunction in amyotrophic lateral sclerosis.
Journal: Brain : a journal of neurology
Published: April 21, 2024
Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo.
Journal: Nature communications
Published: January 23, 2024
PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Journal: Acta neuropathologica
Published: October 20, 2023
Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation.
Journal: European journal of neurology
Published: September 28, 2021
Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis.
Journal: Molecular cell
Published: January 31, 2020
C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A.
Journal: Acta neuropathologica
Published: May 22, 2018
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo.
Journal: EMBO molecular medicine
Published: November 09, 2017
Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD.
Journal: Acta neuropathologica
Published: September 24, 2017
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies.
Journal: EMBO molecular medicine
Published: May 24, 2017
Last Updated: 09/26/2026